Literature DB >> 6323193

Electrophysiological and pharmacological actions of the convulsant benzodiazepine Ro 5-4864.

B A Weissman, J Cott, D Hommer, S Paul, P Skolnick.   

Abstract

Ro 5-4864 (4'-chlorodiazepam) elicited convulsions in mice with a CD50 of 23.5 mg/kg (i.p.) and increased the firing rate of substantia nigra zona reticulata neurons in a dose dependent fashion (0.5-4 mg/kg i.v.). Diazepam and clonazepam, but not Ro 15-1788, were potent inhibitors of Ro 5-4864 induced convulsions. Ro 15-1788 was also ineffective in reversing Ro 5-4864 induced increases in cell firing of zone reticulata neurons. Muscimol potently inhibited the seizures and reversed increases in cell firing elicited by Ro 5-4864. Phenobarbital and pentobarbital inhibited Ro 5-4864 induced convulsions with moderate potencies, while phenytoin and carbamazepine were ineffective at doses of up to 100 mg/kg. These observations suggest that Ro 5-4864 does not elicit its pharmacologic actions through a direct action at a 'brain-type' benzodiazepine receptor. However, both the profile and potency of compounds effective in inhibiting the electrophysiological and pharmacological effects of Ro 5-4864 suggest that this compound may act by perturbation of a component of the GABA-benzodiazepine receptor chloride ionophore complex. These findings do not, however, rule out a direct involvement of the high affinity 'peripheral-type' benzodiazepine receptors found in brain.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323193     DOI: 10.1016/0014-2999(84)90457-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  9 in total

1.  Effect of phosphamidon on convulsive behavior and biochemical parameters: modulation by progesterone and 4'-chlorodiazepam in rats.

Authors:  Vikas Joshi; Tarun Arora; Ashish K Mehta; Amit K Sharma; Naveen Rathor; Kapil D Mehta; Prabha Mahajan; Pramod K Mediratta; Basu D Banerjee; Krishna K Sharma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-08-25       Impact factor: 3.000

2.  Modulatory effect of alpha 2 adrenoceptor agonists on Ro 5-4864-induced convulsions in rats and mice.

Authors:  J Kunchandy; S K Kulkarni
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

3.  Clozapine and some other antipsychotic drugs may preferentially block the same subset of GABA(A) receptors.

Authors:  R F Squires; E Saederup
Journal:  Neurochem Res       Date:  1997-02       Impact factor: 3.996

Review 4.  Benzodiazepine receptors resolved.

Authors:  J G Richards; P Schoch; H Möhler; W Haefely
Journal:  Experientia       Date:  1986-02-15

5.  Differences in the negative allosteric modulation of gamma-aminobutyric acid receptors elicited by 4'-chlorodiazepam and by a beta-carboline-3-carboxylate ester: a study with natural and reconstituted receptors.

Authors:  G Puia; M R Santi; S Vicini; D B Pritchett; P H Seeburg; E Costa
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

6.  The anxiogenic action of RO 5-4864 in the social interaction test: effect of chlordiazepoxide, RO 15-1788 and CGS 8216.

Authors:  S E File; S Pellow
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

7.  The peripheral benzodiazepine receptor ligand Ro 5-4864 induces supraspinal convulsions in rabbits. Reversal by the central benzodiazepine antagonist Ro 15-1788.

Authors:  M Massotti; D Lucantoni
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

8.  The effect of chronic treatment with peripheral benzodiazepine receptor ligands on behavior and GABAA/benzodiazepine receptors in rat.

Authors:  L Rägo; V Saano; T Auvinen; A Adojaan; R Holma; M M Airaksinen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-10       Impact factor: 3.000

9.  Cueing effects of anxiolytic benzodiazepines (DZP and Ro 11-3128): stereospecificity and antagonism by the convulsant benzodiazepine Ro 5-3663.

Authors:  T U Järbe; A Ostlund; A J Hiltunen
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.